(Q33347086)
Statements
1 reference
A phase II study of ZD0473 given as a short infusion every 3 weeks to patients with advanced or metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group trial, IND 129. (English)
1 reference
K A Gelmon
1 reference
T A Vandenberg
1 reference
L Panasci
1 reference
B Norris
1 reference
M Crump
1 reference
L Douglas
1 reference
W Walsh
1 reference
S J Matthews
1 reference
L K Seymour
1 reference
1 April 2003
1 reference
1 reference
14
1 reference
543-548
1 reference
Identifiers
1 reference
1 reference